Skip to main content
Allen Li, MD, Oncology, Portland, OR, OHSU Hospital

AllenLiMD

Oncology Portland, OR

Hematology/Oncology Fellow

Dr. Li is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Li's full profile

Already have an account?

Education & Training

  • UPMC Medical Education
    UPMC Medical EducationResidency, Internal Medicine, 2015 - 2018
  • University of Pittsburgh School of Medicine
    University of Pittsburgh School of MedicineClass of 2015
  • Johns Hopkins University
    Johns Hopkins UniversityM.S. and B.S., Molecular and Cell Biology, 2006 - 2010
  • Oregon Health & Science University
    Oregon Health & Science UniversityFellowship, Hematology and Medical Oncology

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2017 - 2025
  • OR State Medical License
    OR State Medical License 2018 - 2023
  • PA State Medical License
    PA State Medical License 2015 - 2018
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Genomic Alteration in Metastatic Breast Cancer and its Treatment.  
    Li A, Schleicher SM, Andre F, Mitri ZI., American Society of Clinical Oncology Educational Book. 2020(40):30-43.

Abstracts/Posters

  • Feasibility of real-time serial comprehensive tumor analytics: Pilot study of olaparib and durvalumab in metastatic triple negative breast cancer (mTNBC).
    Li A, Labrie M, Vuky J, Lim JY, Johnson B, Sivagnanam S, Betts C, Coussens L, Corless C, Bergan R, Gray J, Mills G, Mitri Z., ASCO 2020
  • Comparison of Circulating Tumor DNA (ctDNA) sequencing and Tumor-based Genotyping for the Detection of EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC).
    Li A, Dacic S, Burns T, Socinsk, M, Abberbock S, Villaruz L, ASCO 2017
  • Autophagy activity and SMAD4 Status in Patients with Primary Resectable Pancreatic Adenocarcinoma.
    Li A, Zenati M, Krasinskas A, Steve J, Lotze M, Zeh H., Academic Surgical Congress 2013

Professional Memberships

Hospital Affiliations